REPORT ID 234

Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Research Report Forecast 2019-2025

Publish Date
2019
Pages
109
Format
Electronic (PDF)

The Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Research Report Forecast  2019-2025 is a valuable source of insightful data for business strategists. It provides the Non-alcoholic Fatty Liver Disease (NAFLD) Drug industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Non-alcoholic Fatty Liver Disease (NAFLD) Drug market study provides comprehensive data which enhances the understanding, scope and application of this report.
This report provides comprehensive analysis of
Key market segments and sub-segments
Evolving market trends and dynamics
Changing supply and demand scenarios
Quantifying market opportunities through market sizing and market forecasting
Tracking current trends/opportunities/challenges
Competitive insights
Opportunity mapping in terms of technological breakthroughs
 
Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Analysis by Countries :
Germany
France
UK
Russia
Italy
Spain
Benelux

The Major players reported in the market include:
Conatus Pharmaceuticals
Daewoong Pharmaceutical
Galmed International
Kyorin Pharmaceutical
Metabolic Solutions Development
Novartis AG
Phenex Pharmaceuticals
Raptor Pharmaceuticals
TCM Biotech International
...
 
Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Analysis by Product :
Type 1
Type 2
Type 3 

Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Analysis by Application:
Application 1
Application 2
Application 3 

Reasons for Buying this Report
This report provides pin-point analysis for changing competitive dynamics
It provides a forward looking perspective on different factors driving or restraining market growth 
It provides a six-year forecast assessed on the basis of how the market is predicted to grow 
It helps in understanding the key product segments and their future
It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments  
			   
Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Report Forecast  2019-2025

1 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Overview
1.1 Product Overview and Scope of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
1.2 Classification of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
1.2.1 Type 1
1.2.2 Type 2
1.2.3 Type 3
1.3 Application of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
1.3.2 Application 1 
1.3.3 Application 2
1.3.4 Application 3
1.4 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market States Status and Prospect ( 2014-2024) by Countries
1.4.1 Germany
1.4.2 France
1.4.3 UK
1.4.4 Russia
1.4.5 Italy
1.4.6 Spain
1.4.7 Benelux
1.5 Europe Market Size (Value and Volume) of Non-alcoholic Fatty Liver Disease (NAFLD) Drug ( 2014-2024)
1.5.1 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate ( 2014-2024)
1.5.2 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate ( 2014-2024)

2 Europe Economic Impact on Non-alcoholic Fatty Liver Disease (NAFLD) Drug Industry
2.1 Europe Macroeconomic Analysis
2.2 Europe Macroeconomic Environment Development Trend

3 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Manufacturing Cost Analysis
3.1 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Key Raw Materials Analysis
3.1.1 Key Raw Materials
3.1.2 Price Trend of Key Raw Materials
3.1.3 Key Suppliers of Raw Materials
3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
3.2.1 Raw Materials
3.2.2 Labor Cost
3.2.3 Manufacturing Process Analysis of Non-alcoholic Fatty Liver Disease (NAFLD) Drug

4 Industrial Chain, Sourcing Strategy and Downstream Buyers
4.1 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Major Manufacturers in 2015
4.4 Downstream Buyers

5 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Analysis by Manufacturers, Type and Application
5.1 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Competition by Manufacturers
5.1.1 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share of Key Manufacturers (2015 and 2016)
5.1.2 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Share by Manufacturers (2015 and 2016)
5.2 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume and Value) by Type
5.2.1 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type ( 2014-2019)
5.2.2 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Market Share by Type ( 2014-2019)
5.3 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume and Value) by Countries
5.3.1 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Countries ( 2014-2019)
5.3.2 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Market Share by Countries ( 2014-2019)
5.4 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume) by Application

6 Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume, Value and Sales Price)
6.1 Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Value ( 2014-2019)
6.1.1 Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate ( 2014-2019)
6.1.2 Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate ( 2014-2019)
6.1.3 Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend ( 2014-2019)
6.2 Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Manufacturers
6.3 Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type
6.4 Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Application

7 France Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume, Value and Sales Price)
7.1 France Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Value ( 2014-2019)
7.1.1 France Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate ( 2014-2019)
7.1.2 France Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate ( 2014-2019)
7.1.3 France Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend ( 2014-2019)
7.2 France Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Manufacturers
7.3 France Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type
7.4 France Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Application

8 UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume, Value and Sales Price)
8.1 UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Value ( 2014-2019)
8.1.1 UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate ( 2014-2019)
8.1.2 UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate ( 2014-2019)
8.1.3 UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend ( 2014-2019)
8.2 UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Manufacturers
8.3 UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type
8.4 UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Application

9 Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume, Value and Sales Price)
9.1 Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Value ( 2014-2019)
9.1.1 Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate ( 2014-2019)
9.1.2 Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate ( 2014-2019)
9.1.3 Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend ( 2014-2019)
9.2 Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Manufacturers
9.3 Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type
9.4 Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Application

10 Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume, Value and Sales Price)
10.1 Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Value ( 2014-2019)
10.1.1 Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate ( 2014-2019)
10.1.2 Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate ( 2014-2019)
10.1.3 Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend ( 2014-2019)
10.2 Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Manufacturers
10.3 Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type
10.4 Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Application

11 Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume, Value and Sales Price)
11.1 Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Value ( 2014-2019)
11.1.1 Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate ( 2014-2019)
11.1.2 Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate ( 2014-2019)
11.1.3 Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend ( 2014-2019)
11.2 Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Manufacturers
11.3 Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type
11.4 Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Application

12 Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume, Value and Sales Price)
12.1 Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Value ( 2014-2019)
12.1.1 Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate ( 2014-2019)
12.1.2 Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate ( 2014-2019)
12.1.3 Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend ( 2014-2019)
12.2 Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Manufacturers
12.3 Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type
12.4 Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Application

13 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Manufacturers Analysis
13.1 Conatus Pharmaceuticals
13.1.1 Company Basic Information, Manufacturing Base and Competitors
13.1.2 Product Type, Application and Specification
13.1.3 Production, Revenue, Price and Gross Margin ( 2014-2019)
13.1.4 Business Overview
13.2 Daewoong Pharmaceutical
13.2.1 Company Basic Information, Manufacturing Base and Competitors
13.2.2 Product Type, Application and Specification
13.2.3 Production, Revenue, Price and Gross Margin ( 2014-2019)
13.2.4 Business Overview
13.3 Galmed International
13.3.1 Company Basic Information, Manufacturing Base and Competitors
13.3.2 Product Type, Application and Specification
13.3.3 Production, Revenue, Price and Gross Margin ( 2014-2019)
13.3.4 Business Overview
13.4 Kyorin Pharmaceutical
13.4.1 Company Basic Information, Manufacturing Base and Competitors
13.4.2 Product Type, Application and Specification
13.4.3 Production, Revenue, Price and Gross Margin ( 2014-2019)
13.4.4 Business Overview
13.5 Metabolic Solutions Development
13.5.1 Company Basic Information, Manufacturing Base and Competitors
13.5.2 Product Type, Application and Specification
13.5.3 Production, Revenue, Price and Gross Margin ( 2014-2019)
13.5.4 Business Overview
13.6 Novartis AG
13.6.1 Company Basic Information, Manufacturing Base and Competitors
13.6.2 Product Type, Application and Specification
13.6.3 Production, Revenue, Price and Gross Margin ( 2014-2019)
13.6.4 Business Overview
13.7 Phenex Pharmaceuticals
13.7.1 Company Basic Information, Manufacturing Base and Competitors
13.7.2 Product Type, Application and Specification
13.7.3 Production, Revenue, Price and Gross Margin ( 2014-2019)
13.7.4 Business Overview
13.8 Raptor Pharmaceuticals
13.8.1 Company Basic Information, Manufacturing Base and Competitors
13.8.2 Product Type, Application and Specification
13.8.3 Production, Revenue, Price and Gross Margin ( 2014-2019)
13.8.4 Business Overview
13.9 TCM Biotech International
13.9.1 Company Basic Information, Manufacturing Base and Competitors
13.9.2 Product Type, Application and Specification
13.9.3 Production, Revenue, Price and Gross Margin ( 2014-2019)
13.9.4 Business Overview
?

13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List

14 Market Effect Factors Analysis
14.1 Technology Progress/Risk
14.1.1 Substitutes Threat
14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Forecast ( 2019-2025)
15.1 Germany Market Forecast ( 2019-2025)
15.2 France Market Forecast ( 2019-2025)
15.3 UK Market Forecast ( 2019-2025)
15.4 Russia Market Forecast ( 2019-2025)
15.5 Italy Market Forecast ( 2019-2025)
15.6 Spain Market Forecast ( 2019-2025)
15.7 Benelux Market Forecast ( 2019-2025)
15.8 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Forecast by Type ( 2019-2025)
15.9 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Forecast by Application ( 2019-2025)

16 Appendix